Clinical Review

Effects of Exenatide on Diabetes Management and Weight Loss in a VA Population

Author and Disclosure Information

One of the relatively new class of incretin mimetics, exenatide has not been as well studied as some other antidiabetic medications. This study aimed to evaluate how well the drug is working for veterans with type 2 diabetes and how closely VA providers are adhering to established guidelines for use.


 

Recommended Reading

Comparing Antithrombotic Regimens for Diabetic Patients Undergoing PCI
Federal Practitioner
Barriers to Treatment Adherence in Patients with Type 2 Diabetes: A Review
Federal Practitioner
Do Lower Serum Creatinine Levels Increase the Risk of Diabetes?
Federal Practitioner
Impact of Instructor-Directed, Web-Based Education and Health Beliefs
Federal Practitioner
The Niacin Debate Continues: Higher Doses, Please
Federal Practitioner
If You Want Treatment Options, Have a Common Disease!
Federal Practitioner
Hypoglycemia's Effects on Spatial Abilities
Federal Practitioner
Actovegin for Diabetic Neuropathy
Federal Practitioner
Do Diabetic Foot Clinics Spread MRSA?
Federal Practitioner
Eplerenone Decreases Hospitalization Time
Federal Practitioner